Search

  • Select Article Type
  • Abstract Supplements
  • Blood Group Review
  • Call to Arms
  • Hypothesis
  • In Memoriam
  • Interview
  • Introduction
  • Short Report
  • abstract
  • Abstracts
  • Article
  • book-review
  • case-report
  • case-study
  • Clinical Practice
  • Commentary
  • Conference Presentation
  • conference-report
  • congress-report
  • Correction
  • Editorial
  • Editorial Comment
  • Erratum
  • Events
  • Letter
  • Letter to Editor
  • mini-review
  • minireview
  • News
  • non-scientific
  • Obituary
  • original-paper
  • Original Research
  • Pictorial Review
  • Position Paper
  • Practice Report
  • Preface
  • Preliminary report
  • Product Review
  • rapid-communication
  • Report
  • research-article
  • Research Communicate
  • research-paper
  • Research Report
  • Review
  • review -article
  • review-article
  • Review Paper
  • Sampling Methods
  • Scientific Commentary
  • short-communication
  • short-report
  • Student Essay
  • Varia
  • Welome
  • Select Journal
  • Polish Journal Of Microbiology
  • Journal Of Epileptology
  • Advancements Of Microbiology
  • Australasian Journal Of Neuroscience

 

mini-review

Colistin Resistance in Enterobacterales Strains – A Current View

-negative bacilli has led to polymyxins B and E being used once again, as a “salvage” therapy in the patients with CRE (carbapenems-resistant Enterobacteriaceae) infections for which we do not have the better treatment options (Li et al. 2006; Nation and Li 2009; Lim et al. 2010). Orally and topically administered colistin sulphate and parenteral colistin methanesulphonate sodium are designed for the treatment of life-threatening human infections caused by Gram-negative rods. Colistin has been approved

ELŻBIETA M. STEFANIUK, STEFAN TYSKI

Polish Journal of Microbiology , ISSUE 4, 417–427

Article

Malignant middle cerebral artery infarct: A clinical case report

. The prognosis is generally poor, and death occurs in approximately 80% of cases as a result of transtentorial herniation and brainstem compression (Back, Nagaraja, Kapur, & Eslick, 2015). Treatment options include intravenous (IV) thrombolysis within 4.5 hours of stroke onset, endovascular clot retrieval (ECR) within 24 hours of stroke onset and surgical decompressive surgery. Significant studies have shown that early decompressive craniectomy (DC) in patients aged <60 years within 48 hours of

Kwan Yee (Queenie) Leung, Sheila Jala, Rosalind Elliott

Australasian Journal of Neuroscience , ISSUE 1, 5–12

Review Paper

Recent advances in pathophysiology studies and treatment of epilepsy in neurocutaneous disorders

most prominent and recent (up to 2014 year) publications on the treatment and mechanisms of epilepsy in selected neurocutaneous disorders. We aimed to emphasize evidence-based medicine recommendations as well as basic experimental studies dealing with molecular mechanisms of epileptogenesis. Discussion and conclusions. Recent advances in disease-modifying treatment options such as mTOR inhibitors in patients with tuberous sclerosis complex open up new perspectives for neurologists. Traditional

Krzysztof Sadowski, Sergiusz Jóźwiak

Journal of Epileptology , ISSUE 2, 99–108

Case report

The lived experience of adults with myasthenia gravis: A phenomenological study

Myasthenia gravis (MG) is a disorder of the neuromuscular junction (NMJ) that causes fatigue and fluctuating muscle weakness (Hickey, 2009). The physiology of this disease is well understood and there are numerous medically focused articles that outline historical data, randomized controlled trials of treatment options and unusual case studies. The nursing literature about MG is limited and dated. The aim of this study was to examine and understand the lived experiences of

Trudy Keer-Keer

Australasian Journal of Neuroscience , ISSUE 1, 40–46

Review Paper

Failure of a first regimen of monotherapy to control the newly diagnosed epilepsies. What to do next?

Background. Monotherapy is the choice regimen to treat newly diagnosed epilepsies. However, if it fails, several strategies may be followed. Aim. To discuss the treatment options when an initial monotherapy regimen fails. Methods. We reviewed the relevant literature on the topic by using PubMed. Review and Discussion. Approximately 64% of people with epilepsy (PWE) de novo are free of seizures with the first appropriate antiepileptic drug (AED) in monotherapy. The type (first versus second

José Pimentel

Journal of Epileptology , ISSUE 2, 109–112

Article

CARBAPENEMASE OF INTESTINAL RODS – THE BEGINNING OF POST-ANTIBIOTIC ERA?

needs be noted that currently other class D carbapenemases have also been detected, i.e. OXA-23, OXA-24/40, OXA-51, OXA-58, OXA-134a, OXA-143, OXA-211, OXA-213, OXA-214, OXA-229 and OXA-235 mainly in Acinetobacter bacteria and in particular A. baumannii, while they have not been detected in the species K. pneumoniae [45]. 3. Review of antibiotic treatment options of infections due to carbapenem-resistant strains Gram-negative bacteria producing KPC, MBL or OXA-48 type carbapenemases are

Sylwia Joanna Chmielewska, Katarzyna Leszczyńska

Postępy Mikrobiologii - Advancements of Microbiology , ISSUE 3, 271–289

Article

POSSIBILITIES OF PREVENTION AND TREATMENT OF HUMAN CYTOMEGALOVIRUS INFECTIONS INCLUDING NEW DRUGS AND COMPOUNDS WITH POTENTIAL APPLICATION

Anna Majewska, Beata Młynarczyk-Bonikowska, Magdalena Malejczyk, Sławomir Majewski, Grażyna Młynarczyk

Postępy Mikrobiologii - Advancements of Microbiology , ISSUE 3, 291–299

No Record Found..
Page Actions